IMPUTE Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.58M
- Investors
-
3
IMPUTE General Information
Description
Developer of digital therapy applications designed to treat autism spectrum disorder. The company's platform leverages artificial intelligence and advanced tracking technologies to deliver personalized therapy programs tailored to child-specific needs, enabling patients with remote access to therapy, improving accessibility and convenience for families, and providing data-driven insights for treatment progress.
Contact Information
Website
www.impute.co.jpCorporate Office
- Marunouchi Nijubashi Building 2nd Floor
- Marunouchi 3-2-2 Chiyoda-Ku
- Tokyo, 100-0005
- Japan
Corporate Office
- Marunouchi Nijubashi Building 2nd Floor
- Marunouchi 3-2-2 Chiyoda-Ku
- Tokyo, 100-0005
- Japan
IMPUTE Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 11-Jan-2022 | $1.58M | Completed | Generating Revenue | ||
| 1. Seed Round | 29-May-2020 | Completed | Generating Revenue |
IMPUTE Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class A Preferred | ||||||||
| AA Class Preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
IMPUTE Patents
IMPUTE Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022190227-A1 | Diagnostic assistance device and method | Inactive | 10-Mar-2021 | ||
| WO-2022123706-A1 | Autism treatment assisting system, autism treatment assisting apparatus, and program | Inactive | 09-Dec-2020 | ||
| JP-2020202971-A | Stress suppression system | Pending | 17-Jun-2019 | ||
| WO-2020189760-A1 | Autism treatment assistant system, autism treatment assistant device, and program | Inactive | 19-Mar-2019 | ||
| JP-2020151092-A | Autism treatment support system, autism treatment support device, and program | Active | 19-Mar-2019 | A61B5/163 |
IMPUTE Signals
IMPUTE Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| I-nest Capital | Venture Capital | Minority | ||
| Arco Partners | Family Office | Minority | ||
| Tx Entrepreneur Partners | Angel Group | Minority |
IMPUTE FAQs
-
When was IMPUTE founded?
IMPUTE was founded in 2017.
-
Where is IMPUTE headquartered?
IMPUTE is headquartered in Tokyo, Japan.
-
What is the size of IMPUTE?
IMPUTE has 15 total employees.
-
What industry is IMPUTE in?
IMPUTE’s primary industry is Other Healthcare Technology Systems.
-
Is IMPUTE a private or public company?
IMPUTE is a Private company.
-
What is the current valuation of IMPUTE?
The current valuation of IMPUTE is .
-
What is IMPUTE’s current revenue?
The current revenue for IMPUTE is .
-
How much funding has IMPUTE raised over time?
IMPUTE has raised $2.05M.
-
Who are IMPUTE’s investors?
I-nest Capital, Arco Partners, and Tx Entrepreneur Partners have invested in IMPUTE.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process